Showing 5,805 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Adherence

Providing ‘fast-track’ HIV treatment refills improves adherence

Editor's pick
Be In The Know
17 August 2022
Pregnancy and vertical transmission

Traditional, alternative HIV regimens yield similar results in pregnancy

Editor's pick
Healio
11 August 2022
Coronavirus

Major Update to the COVID-19 Treatment Guidelines

Editor's pick
HIV.gov
11 August 2022
Access to healthcare

HIV patients in India protest shortage of drugs

Editor's pick
Deutsche Welle
10 August 2022
Injectable & long-acting HIV treatment

Long-Acting Injectable HIV Therapy for People Who Won’t Take ART?

Editor's pick
NEJM Journal Watch
10 August 2022
Treatment outcomes & life expectancy

Immune Recovery, Integrase Inhibitors Improve Survival for People With Late HIV Diagnosis

Editor's pick
POZ
9 August 2022
Child developmental issues

Differences in Early Growth Small for ART-Conceived Infants

Editor's pick
HealthDay News
9 August 2022
Injectable & long-acting HIV treatment

New formulations and alternative injection sites might allow self-administration of long-acting cabotegravir and rilpivirine

News
9 August 2022
Treatment outcomes & life expectancy

Biktarvy Shows Durable Viral Suppression After 5 Years

Editor's pick
Infectious Disease Special Edition
5 August 2022
Weight gain & lipodystrophy

Switching From Integrase Inhibitor to PI Trims Weight in HIV Patient Database

Editor's pick
NATAP
5 August 2022
Treatment simplification strategies

Macrophage Activation for 2 Years After Switch From 3 to 2 Antiretrovirals

Editor's pick
NATAP
5 August 2022
Mental & emotional health & wellbeing

Lonely People With HIV Are More Likely to Skip Treatment

Editor's pick
POZ
3 August 2022
HIV treatment

Dolutegravir Around the World: Outcomes in Advanced AIDS and Maintenance Therapy

Editor's pick
TheBodyPro
2 August 2022
Support issues for children & young people

“Your status cannot hinder you”: A report on resilience among adolescents engaged in HIV care in Kenya

Editor's pick
Be In The Know
2 August 2022
Coronavirus

HIV Virologic Suppression Rates Before vs During the COVID-19 Pandemic

Editor's pick
Infectious Disease Advisor
2 August 2022
Violence

Adolescents and women who experience violence more likely to get HIV and less likely to control it

News
2 August 2022
Resistance

Fostemavir Improves Outcomes for Treatment-Resistant HIV Patients

Editor's pick
Contagion Live
1 August 2022
Hepatitis B

Biktarvy combination pill may be most effective option for people with HIV and hepatitis B

News
31 July 2022
Weight gain & lipodystrophy

Weight gain on treatment: more evidence that TAF plus dolutegravir leads to greater gains

News
29 July 2022
HIV treatment

Mozambique: Half a Million HIV-Positive People Abandon Anti-Retroviral Treatment

Editor's pick
AllAfrica
29 July 2022
New & experimental HIV treatments

Gilead Sciences Statement on FDA Acceptance of New Drug Application for Investigational Lenacapavir

Editor's pick
Gilead Sciences press release
28 July 2022
Adherence

Motivational Interviewing May Increase Antiretroviral Therapy Adherence in Patients With HIV

Editor's pick
Infectious Disease Advisor
22 July 2022
PrEP

PrEP State of the Union: Adherence, Access, Uptake Issues

Editor's pick
Contagion Live
22 July 2022
Treatment outcomes & life expectancy

Risk of Mortality Similar Between Most First-Line Antiretroviral Regimens for HIV

Editor's pick
Infectious Disease Advisor
11 July 2022